Selected Publications

Townsend, T., Kline, D. (joint first author), Rivera-Aguirre, A., Bunting, A.M., Mauro, P.M., Martins, S.S., Marshall, B.D.L.., Cerdá, M. (Forthcoming.) Racial/ethnic and geographic trends in combined stimulant/opioid overdoses, 2007-2019. American Journal of Epidemiology.

Townsend, T., Bohnert, A.S.B., Merlin, J. (Forthcoming.) Opioid prescribing to patients with advanced cancer: Unanswered questions. Journal of Clinical Oncology.

Townsend, T., Cerdá, M., Bohnert, A., Lagisetty, P., & Haffajee, R. L. (2021). CDC guideline for opioid prescribing associated with reduced dispensing to certain patients with chronic pain.. Health Affairs40(11), 1766-1775.

Townsend, T., Salz, T., Haffajee, R.L., Caram, M.E.V, Chino, F., Bohnert, A.S.B. (2021). Has declining opioid dispensing to patients with cancer been tailored to risk of opioid harms? Journal of Pain and Symptom Managementdoi.org/10.1016/j.jpainsymman.2021.09.014

Townsend, T., & Mehta, N. K. (2021). Pathways to educational disparities in disability incidence: The contributions of excess body mass index, smoking, and manual labor involvement. The Journals of Gerontology: Series B76(4), 766-777. doi.org/10.1093/geronb/gbaa085

Townsend, T., Blostein, F., Doan, T., Madson-Olson, S., Galecki, P., & Hutton, D. W. (2020). Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. International Journal of Drug Policy, 75, 102536. doi.org/10.1016/j.drugpo.2019.07.031

Mauri, A. I., Townsend, T., & Haffajee, R. L. (2020). The association of state opioid misuse prevention policies with patient‐and provider‐related outcomes: a scoping review. The Milbank Quarterly98(1), 57-105. doi.org/10.1111/1468-0009.12436

Townsend, T. N., & Mehta, N. K. (2020). Contributions of obesity and cigarette smoking to incident disability: A longitudinal analysis. Preventive Medicine, 141, 106226. doi.org/10.1016/j.ypmed.2020.106226


Selected Honors and Awards

2021-2022 NYU Center for Opioid Epidemiology and Policy Pilot Award ($7,000)
Project title: Pathways to racial disparities in the effects of Good Samaritan Laws

2020-2022      NYU Behavioral Sciences Training Postdoc Fellowship (NIDA T32)

2018-2020       Univ. Michigan Population Studies Center Traineeship (NIA T32) 

2016-2018       Michigan Public Health Regents’ Fellowship

2013-2014       Henry Luce Scholarship

2012-2013       DAAD Graduate Study Scholarship

2008-2012      Indiana University Wells Scholarship


Selected Media Coverage and Public Engagement

Townsend, T., Blostein, F. “This overdose-reversal medicine could reduce opioid deaths – so why don’t more people carry it?” The Conversation. 18 October 2019. Picked up by The Chicago TribuneThe Baltimore SunPopular Science, and other outlets, via the Associated Press.

Townsend, T. (2019, August 22). Radio interview: WEMU-FM (NPR Affiliate). Interviewer: Jorge Avellan.

AcademyHealth. (2017, June 27). Studies identify new risk factors for long-term opioid use, cost-effectiveness of naloxone distribution [Press release].


Contact: tarlise.townsend@nyulangone.org


%d bloggers like this: